Faster, Better? Fujitsu, Polarisqb 'Quantum-Inspired' Tech Speeds Discovery
Promise Vs Coronavirus?
Executive Summary
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.
You may also be interested in...
ASCO 2020: Positive Early Data For Keytruda/Lenvima In Liver, Kidney Cancer
Partners say they are encouraged by new overall response data from early trials for the two drugs together in kidney and liver cancer, presented to ASCO.
Deal Watch: Chinook To Go Public Via Reverse Merger With Troubled Aduro
Focused on precision medicine for renal disease, Chinook gets Aduro’s Nasdaq listing and starting capital of $200m. During a wave of modest-sized M&A deals, Tetra finds buyer, Tetraphase gets competing bids.
ASCO 2020: Pevonedistat Shows Promise In Higher-Risk MDS
Takeda is confident about the promise of its first-in-class molecule for higher-risk myelodysplastic syndromes after positive Phase II data.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports